Synaptogenix (SNPX) Stock Statistics & Valuation Metrics

Synaptogenix has a market cap or net worth of $4.86M. The enterprise value is $165.21M.

Synaptogenix has 1,389,815 shares outstanding. The number of shares has decreased by -2.65% in one year.

Synaptogenix’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -41.54%.

The current PE Ratio of Synaptogenix is -0.34. Synaptogenix’s PEG ratio is 0.54.

In the last 12 months, Synaptogenix had revenue of 0.00 and earned -12.77M in profits. Earnings per share was 10.99M.

In the last 12 months, operating cash flow was -5.05M and capital expenditures 0.00, giving a free cash flow of -5.05M billion.

Synaptogenix pays an annual dividend of ―, resulting in a dividend yield of ―

Synaptogenix upcoming earnings date is ―, TBA Not Confirmed.

Synaptogenix as a current ratio of <0.01, with Debt / Equity ratio of 0.00%

In the past 12 months, Synaptogenix has paid -789.91B in taxes.

Synaptogenix EV to EBITDA ratio is 1.05, with an EV/FCF ratio of 2.74.

Synaptogenix has $14.83M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$14.83M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Synaptogenix is ―, which is 11.43% higher than the current price. The consensus rating is ―